The epithelial-mesenchymal transition generates cells with properties of stem cells

Author(s): Mani A, Guo W, Liao MJ, Eaton E, Ayyanan A, et al.

Abstract

The epithelial-mesenchymal transition (EMT) is a key developmental program that is often activated during cancer invasion and metastasis. We here report that the induction of an EMT in immortalized human mammary epithelial cells (HMLEs) results in the acquisition of mesenchymal traits and in the expression of stem-cell markers. Furthermore, we show that those cells have an increased ability to form mammospheres, a property associated with mammary epithelial stem cells. Independent of this, stem cell-like cells isolated from HMLE cultures form mammospheres and express markers similar to those of HMLEs that have undergone an EMT. Moreover, stem-like cells isolated either from mouse or human mammary glands or mammary carcinomas express EMT markers. Finally, transformed human mammary epithelial cells that have undergone an EMT form mammospheres, soft agar colonies, and tumors more efficiently. These findings illustrate a direct link between the EMT and the gain of epithelial stem cell properties.

Similar Articles

Role of altered expression of HLA class I molecules in cancer progression

Author(s): Aptsiauri N, Cabrera T, Mendez R, Garcia-Lor A, Ruiz-Cabello F, et al.

β-Arrestin-dependent, G protein-independent ERK1/2 activation by the 2-adrenergic receptor

Author(s): Shenoy SK, Drake MT, Nelson CD, Houtz DA, Xiao K, et al.

Human T cell responses against melanoma

Author(s): Boon T, Coulie PG, Van Den Eynde BJ, Van Der Bruggen P

Mutations in GNA11 in Uveal Melanoma

Author(s): Van Raamsdonk C, Griewank K, Michelle B, Crosby MB, Garrido MC, et al.

Cohesin‐SA1 deficiency drives aneuploidy and tumourigenesis in mice due to impaired replication of telomeres

Author(s): Remeseiro S, Cuadrado A, Carretero M, Martínez P, Drosopoulos WC, et al.

MDM4 is a key therapeutic target in cutaneous melanoma

Author(s): Gembarska A, Luciani F, Fedele C, Russell EA, Dewaele A, et al.

Epithelial–mesenchymal transition in cancer development and its clinical significance

Author(s): Iwatsuki M, Mimori K, Yokobori T, Ishi H, Beppu T, et al.

RAGE is the major receptor for the proinflammatory activity of HMGB1 in rodent macrophages

Author(s): Kokkola R, Andersson A, Mullins G, Östberg T, Treutiger CJ, et al.

CTLA-4 and PD-1 receptors inhibit T-cell activation by distinct mechanisms

Author(s): Parry RV, Chemnitz JM, Frauwirth KA, Lanfranco AR, Braunstein I, et al.

B7-H1 is a ubiquitous antiapoptotic receptor on cancer cells

Author(s): Azuma T, Yao S, Zhu G, Flies A, Flies S, et al.

Breast cancer version 3

Author(s): Gradishar W, Anderson B, Blair S, Burstein H, Cyr A, et al.

In situ tumor PD-L1 mRNA expression is associated with increased TILs and better outcome in breast carcinomas

Author(s): Schalper K, Velcheti V, Carvajal D, Wimberly H, Brown J, et al.

Expression of programmed death ligand 1 (PD-L1) is associated with poor prognosis in human breast cancer

Author(s): Muenst S, Schaerli AR, Gao F, Däster S, Trella E, et al.

Radiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancer

Author(s): Twyman-Saint VC, Rech AJ, Maity A, Rengan R, Pauken KE, et al.

Aspirin and P2Y12 inhibition attenuate platelet-induced ovarian cancer cell invasion

Author(s): Cooke NM, Spillane CD, Sheils O, O’Leary J, Kenny D

Immune cell promotion of metastasis

Author(s): Kitamura T, Qian BZ, Pollard JW

FOXP3+regulatory T cells affect the development and progression of hepatocarcinogenesis

Author(s): Kobayashi N, Hiraoka N, Yamagami W, Ojima H, Kanai Y, et al.

Methylation not a frequent “second hit” in tumors with germline BRCA mutations

Author(s): Dworkin AM, Spearman A, Tseng S, Sweet K, Amanda AE

Epithelial-mesenchymal transitions in development and disease

Author(s): Thiery JP, Acloque H, Huang R, Nieto A

Molecular biomarker in prostate cancer: The role of CpG island hypermethylation

Author(s): Bastian P, Yegnasubramanian S, Palapattu G, Rogers C, Lin X, et al.

Molecular epigenetics and genetics in neuro-oncology

Author(s): Nagarajan R, Costello J